CHICAGO (AP) — For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions…
Source:New drugs may make a dent in lung, ovarian cancer
Saturday, May 31, 2014
New drugs may make a dent in lung, ovarian cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment